Pulmonary-Allergy Drug Advisory Committee; Cancellation, 6518 [E8-1959]

Download as PDF 6518 Federal Register / Vol. 73, No. 23 / Monday, February 4, 2008 / Notices Dated: January 24, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–2013 Filed 2–1–08; 8:45 am] BILLING CODE 4163–18–P Description: A voluntary program which provides State Child Support Enforcement agencies, upon their request, access to the earned and unearned income information reported to IRS by employers and financial institutions. The IRS 1099 information is used to locate noncustodial parents and to verify income and employment. Respondents: State IV–D programs. DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Project 1099. OMB No.: 0970–0183. ANNUAL BURDEN ESTIMATES Number of respondents Instrument 1099 Record specifications ............................................................................. IRS Safeguarding Certification Letter .............................................................. Estimated Total Annual Burden Hours: 1,296. Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: infocollection@acf.hhs.gov. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202– 395–6974, Attn: Desk Officer for the Administration for Children and Families. 54 54 SUMMARY: The meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for February 20, 2008, is cancelled. This meeting was announced in the Federal Register of December 21, 2007 (72 FR 72737). FOR FURTHER INFORMATION CONTACT: Teresa A. Watkins, Center for Drug Evaluation and Research (HFD–21), Food and Drug Administration, 5630 Fishers Lane (for express delivery, rm. 1093), Rockville, MD 20857, 301–827– 7001, FAX: 301–827–6776, e-mail: Teresa.Watkins@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512545. Please call the Information Line for up-to-date information on this meeting. ebenthall on PRODPC61 with NOTICES Food and Drug Administration Pulmonary-Allergy Drug Advisory Committee; Cancellation Food and Drug Administration, Notice. VerDate Aug<31>2005 15:15 Feb 01, 2008 Jkt 214001 1.96 .48 1,270 26 Clinical Center, including consideration of personnel qualifications and performance and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors of the NIH Clinical Center. Date: February 25, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate Imaging Sciences Review. Place: National Institutes of Health, Building 10, 10 Center Drive, CRC—Room 4– 2551, Bethesda, MD 20892. Contact Person: David K. Henderson, MD, Deputy Director for Clinical Care, Office of the Director, Clinical Center, National Institutes of Health, Building 10, Room 6– 1480, Bethesda, MD 20892, (301) 496–3515. Dated: January 24, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 08–465 Filed 2–1–08; 8:45 am] BILLING CODE 4160–01–S BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Clinical Center; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES ACTION: 12 1 Total burden hours Dated: January 29, 2008. Randall W. Lutter, Deputy Commissioner for Policy. [FR Doc. E8–1959 Filed 2–1–08; 8:45 am] National Institute of General Medical Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors of the NIH Clinical Center. The meetings will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), title 5 U.S.C., as amended, for the review, discussion, and evaluation of individual intramural programs and projects conducted by the Pursuant to section 120(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, BILLING CODE 4184–01–M HHS. Average burden hours per response National Institutes of Health Dated: January 25, 2008. Janean Chambers, Reports Clearance Officer. [FR Doc. 08–446 Filed 2–1–08; 8:45 am] AGENCY: Number of responses per respondent PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM 04FEN1

Agencies

[Federal Register Volume 73, Number 23 (Monday, February 4, 2008)]
[Notices]
[Page 6518]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-1959]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Pulmonary-Allergy Drug Advisory Committee; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Pulmonary-Allergy Drugs Advisory Committee 
scheduled for February 20, 2008, is cancelled. This meeting was 
announced in the Federal Register of December 21, 2007 (72 FR 72737).

FOR FURTHER INFORMATION CONTACT: Teresa A. Watkins, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5630 
Fishers Lane (for express delivery, rm. 1093), Rockville, MD 20857, 
301-827-7001, FAX: 301-827-6776, e-mail: Teresa.Watkins@fda.hhs.gov, or 
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 
in the Washington, DC area), code 3014512545. Please call the 
Information Line for up-to-date information on this meeting.

    Dated: January 29, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-1959 Filed 2-1-08; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.